Transcatheter renal artery sympathetic denervation for resistant hypertension: an old paradigm revisited

International Journal of Cardiology
Guang-Ming TamYat-Yin Lam

Abstract

Resistant hypertension, defined as the failure to achieve target blood pressure despite concurrent use of 3 antihypertensive agents of different classes, is estimated to affect 20-30% of hypertensive patients. These patients are vulnerable to cardiovascular, cerebrovascular and renal complications. There is ample evidence that sympathetic nervous system hyperactivity contributes to the initiation, maintenance and progression of hypertension. The renal sympathetic nervous system, in particular, has been identified as a major culprit for the development and progression of hypertension, heart failure and chronic kidney disease in both preclinical and human studies. Traditional surgical sympathectomy proposed in 1940s was halted due to unacceptable operative risk and the emergence of anti-hypertensive medications. Recently, catheter-based renal sympathetic denervation by radiofrequency ablation has shown encouraging intermediate-term results with minimal complications in patients with resistant hypertension. This review summarizes the patho-physiological role of the renal sympathetic nervous system and the potential application of renal denervation therapy for the treatment of resistant hypertension.

References

May 1, 1992·Canadian Journal of Physiology and Pharmacology·L BarajasK Powers
Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Feb 20, 2002·JAMA : the Journal of the American Medical Association·JoAnne Micale FoodyHarlan M Krumholz
Oct 9, 2002·Circulation·Martin HausbergKarl Heinz Rahn
Mar 8, 2003·Hypertension·Gerald F DiBona
Jan 26, 2011·Neurology·N K PatelJ F R Paton

❮ Previous
Next ❯

Citations

Dec 1, 2012·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·W L VerloopP A Doevendans
Apr 26, 2016·International Journal of Cardiology·Katsunori NonogakiNariki Kubota
Jan 25, 2014·International Journal of Cardiology·Hitesh C Patel, Tushar V Salukhe
Dec 18, 2013·International Journal of Cardiology·E ImbalzanoA Saitta
Feb 20, 2013·International Journal of Cardiology·Katsunori NonogakiNariki Kubota
Feb 14, 2015·European Journal of Internal Medicine·Lene Kjær OlsenBo Feldt-Rasmussen
Jan 10, 2014·Angiology·Thomas D GossiosHaralambos Karvounis
Jan 4, 2013·The Journal of Clinical Hypertension·Priyanka GosainRajender Agarwal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Related Papers

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
W L VerloopP A Doevendans
The American Journal of Cardiology
Michael DoumasVasilios Papademetriou
© 2022 Meta ULC. All rights reserved